Literature DB >> 2154530

Mapping of low abundance latency-associated RNA in the trigeminal ganglia of mice latently infected with herpes simplex virus type 1.

W J Mitchell1, R P Lirette, N W Fraser.   

Abstract

During herpes simplex virus type 1 (HSV-1) latent infection of the mouse trigeminal ganglion there is limited viral gene expression. The latency-associated transcripts (LAT) map approximately to the PstI-MluI fragment within the BamHI B and BamHI E fragments (long repeat regions) of the viral genome. Additional weak hybridization signals have been detected by in situ hybridization that correspond to transcription from HSV-1 DNA fragments adjacent tot he PstI-MluI fragment. We mapped the region encoding this additional transcription. This minor latency-associated RNA (m-LAT) was shown to map to a group of contiguous fragments (approximately 8.3 kb of DNA), which are adjacent to the 3' end of LAT and to a (2.0 kb) fragment adjacent to the 5' end of the LAT. Using single-stranded probes in in situ hybridization experiments, we showed that the KpnI-BamHI and BamHI-SacI regions of m-LAT are transcribed in a rightward direction within the long internal repeat region. This low abundance RNA may be related to the previously described LAT.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2154530     DOI: 10.1099/0022-1317-71-1-125

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  66 in total

1.  Enhancer and long-term expression functions of herpes simplex virus type 1 latency-associated promoter are both located in the same region.

Authors:  H Berthomme; J Thomas; P Texier; A Epstein; L T Feldman
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Neither LAT nor open reading frame P mutations increase expression of spliced or intron-containing ICP0 transcripts in mouse ganglia latently infected with herpes simplex virus.

Authors:  Shun-Hua Chen; Lily Yeh Lee; David A Garber; Priscilla A Schaffer; David M Knipe; Donald M Coen
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

3.  Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR.

Authors:  R J Cohrs; J Randall; J Smith; D H Gilden; C Dabrowski; H van Der Keyl; R Tal-Singer
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Localization of cis-acting sequence requirements in the promoter of the latency-associated transcript of herpes simplex virus type 1 required for cell-type-specific activity.

Authors:  A H Batchelor; P O'Hare
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

5.  Localization of herpes simplex virus type 1 DNA in latently infected BALB/c mice neurons using in situ polymerase chain reaction.

Authors:  Behzad Khansarinejad; Hoorieh Soleimanjahi; Amir Ghaemi; Taki Tiraihi; Shahram Pour Beiranvand
Journal:  Iran Biomed J       Date:  2010-07

6.  Cloning of the latency gene and the early protein 0 gene of pseudorabies virus.

Authors:  A K Cheung
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

7.  A herpes simplex virus type 1 mutant lacking the ICP0 introns reactivates with normal efficiency.

Authors:  R Natarajan; S Deshmane; T Valyi-Nagy; R Everett; N W Fraser
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

8.  Modulation of reactivation of latent herpes simplex virus 1 in ganglionic organ cultures by p300/CBP and STAT3.

Authors:  Te Du; Guoying Zhou; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-20       Impact factor: 11.205

9.  Identification of herpes simplex virus type 1 proteins encoded within the first 1.5 kb of the latency-associated transcript.

Authors:  Gail Henderson; Tareq Jaber; Dale Carpenter; Steven L Wechsler; Clinton Jones
Journal:  J Neurovirol       Date:  2009-09       Impact factor: 2.643

10.  Two open reading frames (ORF1 and ORF2) within the 2.0-kilobase latency-associated transcript of herpes simplex virus type 1 are not essential for reactivation from latency.

Authors:  M U Fareed; J G Spivack
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.